Research Article

You have full text access to this OnlineOpen article

Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus

  1. Pierre Chagnon1,
  2. Rayfel Schneider2,
  3. Josée Hébert3,
  4. Paul R. Fortin4,
  5. Sylvie Provost1,
  6. Claude Belisle1,
  7. Marianne Gingras1,
  8. Véronique Bolduc1,
  9. Claude Perreault1,
  10. Earl Silverman2,
  11. Lambert Busque5,†,*

Article first published online: 30 MAR 2006

DOI: 10.1002/art.21733

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 54, Issue 4, pages 1270–1278, April 2006

Additional Information

How to Cite

Chagnon, P., Schneider, R., Hébert, J., Fortin, P. R., Provost, S., Belisle, C., Gingras, M., Bolduc, V., Perreault, C., Silverman, E. and Busque, L. (2006), Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis & Rheumatism, 54: 1270–1278. doi: 10.1002/art.21733

Author Information

  1. 1

    University of Montreal, Montreal, Quebec, Canada

  2. 2

    Hospital for Sick Children, Toronto, Ontario, Canada

  3. 3

    University of Montreal, and Banque de Cellules Leucémiques du Québec, Montreal, Quebec, Canada

  4. 4

    Arthritis Centre of Excellence, University Health Network, Toronto, Ontario, Canada

  5. 5

    University of Montreal, and HemaX Genome, Montreal, Quebec, Canada

  1. †

    Dr. Busque is a minority stockholder in HemaX Genome, a subsidiary of Emerillon.

*Centre de Recherche, Hôpital Maisonneuve-Rosemont, 5415 Boulevard de l'Assomption, Montreal, Quebec H1T 2M4, Canada

Publication History

  1. Issue published online: 30 MAR 2006
  2. Article first published online: 30 MAR 2006
  3. Manuscript Accepted: 30 DEC 2005
  4. Manuscript Received: 6 JAN 2005

Funded by

  • HemaX Genome
  • Arthritis Society of Canada
  • Institute of Musculoskeletal Health and Arthritis
  • Canada Research Chair in Immunology

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (250K)

REFERENCES

  • 1
    Bader-Meunier B, Quartier P, Deschenes G, Cochat P, Haddad E, Kone-Paut I, et al. Childhood-onset systemic lupus erythematosus. Arch Pediatr 2003; 10: 147–57.
  • 2
    Wenzel J, Gerdsen R, Uerlich M, Bauer R, Tueting T, Bieber T. Lymphocytopenia in lupus erythematosus: close in vivo association to autoantibodies targeting nuclear antigens. Br J Dermatol 2004; 150: 994–8.
    Direct Link:
  • 3
    Kelly JA, Moser KL, Harley JB. The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 2002; 3 Suppl 1: S71–85.
  • 4
    Grennan DM, Parfitt A, Manolios N, Huang Q, Hyland V, Dunckley H, et al. Family and twin studies in systemic lupus erythematosus. Dis Markers 1997; 13: 93–8.
  • 5
    Waters ST, Fu SM, Gaskin F, Deshmukh US, Sung SS, Kannapell CC, et al. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin Immunol 2001; 100: 372–8.
  • 6
    Namjou B, Nath SK, Kilpatrick J, Kelly JA, Reid J, Reichlin M, et al. Genome scan stratified by the presence of anti-double-stranded DNA (dsDNA) autoantibody in pedigrees multiplex for systemic lupus erythematosus (SLE) establishes linkages at 19p13. 2 (SLED1) and 18q21.1 (SLED2). Genes Immun 2002; 3 Suppl 1: S35–41.
  • 7
    Quintero-Del-Rio AI, Kelly JA, Kilpatrick J, James JA, Harley JB. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun 2002; 3 Suppl 1: S57–62.
  • 8
    Harley JB, Kelly JA. Genetic basis of systemic lupus erythematosus: a review of the unique genetic contributions in African Americans. J Natl Med Assoc 2002; 94: 670–7.
  • 9
    Gaffney PM, Kearns GM, Shark KB, Ortmann WA, Selby SA, Malmgren ML, et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci U S A 1998; 95: 14875–9.
  • 10
    Nath SK, Kelly JA, Reid J, Lam T, Gray-McGuire C, Namjou B, et al. SLEB3 in systemic lupus erythematosus (SLE) is strongly related to SLE families ascertained through neuropsychiatric manifestations. Hum Genet 2002; 111: 54–8.
  • 11
    Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 778–99.
    Direct Link:
  • 12
    Sekigawa I, Naito T, Hira K, Mitsuishi K, Ogasawara H, Hashimoto H, et al. Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 2004; 13: 217–22.
  • 13
    Gilliland WR, Stashower ME. Klinefelter's syndrome and systemic lupus erythematosus. Clin Exp Rheumatol 2000; 18: 107–9.
  • 14
    Simko R, Nagy K, Lombay B, Kiss A, Minik K, Lukacs VH, et al. Multicentric Castleman disease and systemic lupus erythematosus phenotype in a boy with Klinefelter syndrome: long-term disease stabilization with interferon therapy. J Pediatr Hematol Oncol 2000; 22: 180–3.
  • 15
    Olsen NJ, Kovacs WJ. Case report: testosterone treatment of systemic lupus erythematosus in a patient with Klinefelter's syndrome. Am J Med Sci 1995; 310: 158–60.
  • 16
    Folomeev M, Kosheleva N, Alekberova Z. Systemic lupus erythematosus associated with Klinefelter's syndrome: a case report from the USSR. J Rheumatol 1991; 18: 940–1.
  • 17
    Kobayashi S, Shimamoto T, Taniguchi O, Hashimoto H, Hirose S. Klinefelter's syndrome associated with progressive systemic sclerosis: report of a case and review of the literature. Clin Rheumatol 1991; 10: 84–6.
  • 18
    McDonald J, Fam AG, Paton T, Senn J. Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous gout. J Rheumatol 1988; 15: 865–8.
  • 19
    Lahita RG, Bradlow HL. Klinefelter's syndrome: hormone metabolism in hypogonadal males with systemic lupus erythematosus. J Rheumatol Suppl 1987; 14 Suppl 13: 154–7.
  • 20
    Dugernier T, Huaux JP, Coche E, Nagant de Deuxchaisnes C. Klinefelter's syndrome and lupus erythematosus: report of a case. Clin Rheumatol 1987; 6: 84–7.
  • 21
    Stern R, Fishman J, Brusman H, Kunkel HG. Systemic lupus erythematosus associated with Klinefelter's syndrome. Arthritis Rheum 1977; 20: 18–22.
    Direct Link:
  • 22
    Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 1996; 88: 59–65.
  • 23
    Schiebel K, Winkelmann M, Mertz A, Xu X, Page DC, Weil D, et al. Abnormal XY interchange between a novel protein kinase gene PRKY, and its homologue, PRKX, accounts for one third of all (Y+)XX males and (Y–)XY females. Hum Mol Genet 1997; 6: 1985–9.
  • 24
    Ochman H, Gerber AS, Hartl DL. Genetic applications of an inverse polymerase chain reaction. Genetics 1998; 120: 621–3.
  • 25
    Akasaka H, Akasaka T, Kurata M, Ueda C, Shimizu A, Uchiyama T, et al. Molecular anatomy of BLC6 translocations revealed by long-distance polymerase chain reaction-based assay. Cancer Res 2000; 60: 2335–41.
  • 26
    Graves JA, Wakefield MJ, Toder R. The origin and evolution of the pseudoautosomal regions of human sex chromosomes. Hum Mol Genet 1998; 7: 1991–6.
  • 27
    Laurendeau I, Bahuau M, Vodovar N, Larramendy C, Olivi M, Bieche I, et al. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin Chem 1999; 45: 982–6.
  • 28
    Jung KC, Kim NH, Park WS, Park SH, Bae Y. The CD99 signal enhances Fas-mediated apoptosis in the human leukemic cell line, Jurkat. FEBS Lett 2003; 554: 478–84.
  • 29
    Kim MK, Choi YL, Kim MK, Kim SH, Choi EY, Park WS, et al. MHC class II engagement inhibits CD99-induced apoptosis and up-regulation of T cell receptor and MHC molecules in human thymocytes and T cell line. FEBS Lett 2003; 546: 379–84.
View Full Article (HTML) Get PDF (250K)